Previous studies indicated that TNNI3 was predicted as a target of hsamiR-375 in various stages of laryngeal squamous cell carcinoma (LSCC) (Yu et al., 2018). This evidence concerns the gene TNNI3 and laryngeal squamous cell carcinoma.